Evidence map›Paper›PMID 38661037›Full record

ArticleRecent advances in drug delivery and formulation2024

Paola Spínello, Pamela do Nascimento, Verônica Cristina da Silveira, Tatiana Staudt, Hamid Omidian, Ana Caroline Tissiani, Charise Dallazem Bertol

Abstract read
PubMed Publisher
In one paragraph

Article in Recent advances in drug delivery and formulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Paola SpínelloCollege of Pharmacy and Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo/ RS/ Brazil.ORCID 0000-0003-3601-5696
Pamela do NascimentoCollege of Pharmacy and Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo/ RS/ Brazil.ORCID 0000-0001-9523-3736
Verônica Cristina da SilveiraCollege of Pharmacy and Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo/ RS/ Brazil.ORCID 0000-0002-9923-5373
Tatiana StaudtCollege of Pharmacy and Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo/ RS/ Brazil.ORCID 0000-0001-7622-1916
Hamid OmidianCollege of Pharmacy, Nova Southeastern University, Fort Lauderdale, Florida, FL 33328, USA.ORCID 0000-0002-5637-8729
Ana Caroline TissianiCollege of Pharmacy and Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo/ RS/ Brazil.ORCID 0000-0002-9715-2283
Charise Dallazem BertolCollege of Pharmacy and Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo/ RS/ Brazil.ORCID 0000-0001-7596-315X
Universidade de Passo Fundo · BRNova Southeastern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProbiotics must be able to withstand the demanding environment of the gastrointestinal system to adhere to the intestinal epithelium, promoting health benefits. The use of probiotics can prevent or attenuate the effects of dysbiosis that have a deleterious effect on health, promoting anti-inflammatory, immunomodulatory, and antioxidant effects.

objectiveThe aim of the study was to prepare tablets containing

methodsTablet dissolution was evaluated under acidic and basic pH conditions, and aliquots of the dissolution medium were plated to count the Colony-forming Units (CFU). The free probiotic's tolerance to pH levels of 1.0, 2.0, 3.0, and 4.0, as well as to pepsin, pancreatin, and bile salts, was assessed.

resultsThe probiotic was released from tablets coated after they withstood the pH 1.2 acid stage for 45 minutes. The release was higher with the Acry-Eze II

conclusionBoth coating polymers were able to withstand the acid step, likely ensuring the release of the probiotic in the small intestine, promoting colonization. Coating with enteric material is a simple and effective process to increase the survival of probiotics, offering a promising alternative to mitigate the negative effects of the dysbiosis process.

Indexed as

Limosilactobacillus fermentumProbioticsTablets, Enteric-CoatedBile Acids and SaltsHumansHydrogen-Ion ConcentrationPancreatinSolubilityBile Acids and SaltsPancreatinTablets, Enteric-CoatedAcryl-Eze II®CFUenteric coatingL. fermentum.Opadry®probiotics

Identifiers

PMID38661037
OpenAlexW4395466579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.